Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

AEHR Insider Trading

Aehr Test Systems | Instruments For Meas & Testing of Electricity & Elec Signals

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Aehr Test Systems provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Instruments For Meas & Testing of Electricity & Elec Signals sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2022-08-12 23:00 2022-08-10 SLAYEN HOWARD T Director SELL $17.50 10,000 $175,002 190,762 -5.0%
2022-08-10 23:00 2022-08-08 SPINK KENNETH B. Officer - VP of Finance and CFO SELL $16.07 24,526 $394,238 154,673 -13.7%
2022-08-05 23:01 2022-08-04 SLAYEN HOWARD T Director SELL $14.75 10,000 $147,514 200,762 -4.7%
2022-08-04 23:01 2022-08-02 SLAYEN HOWARD T Director SELL $12.50 10,000 $125,000 210,762 -4.5%
2022-04-08 23:11 2022-04-06 Erickson Gayn Director, Officer - President and CEO SELL $9.42 5,000 $47,100 483,764 -1.0%
2022-02-09 01:30 2022-02-07 ROSATI MARIO M Director OPT+S $12.28 2,500 $30,704 36,798 0.0%
2022-01-28 01:01 2022-01-26 Brannan Michael A. Other SELL $12.37 6,025 $74,544 0 -100.0%
2022-01-25 00:00 2022-01-20 Brannan Michael A. Officer - V.P. of Operations OPT+S $12.35 15,350 $189,615 16,373 0.0%
2021-11-17 00:45 2021-11-12 SCOTT GEOFFREY GATES Director SELL $25.40 50,000 $1,270,085 140,000 -26.3%
2021-11-16 00:00 2021-11-11 Erickson Gayn Director, Officer - President and CEO OPT+S $23.29 80,000 $1,862,960 499,847 0.0%
2021-11-09 02:15 2021-11-04 HENDRICKSON DAVID S Officer - CTO OPT+S $25.08 25,000 $627,000 44,402 0.0%
2021-11-09 02:13 2021-11-04 Erickson Gayn Director, Officer - President and CEO SELL $25.75 100,000 $2,575,000 442,753 -18.4%
2021-11-06 00:00 2021-11-03 POSEDEL RHEA J Director SELL $24.91 25,000 $622,750 597,578 -4.0%
2021-11-01 21:33 2021-10-28 OLIPHANT LAURA Director SELL $21.50 11,381 $244,692 21,010 -35.1%
2021-11-01 21:33 2021-10-28 SCOTT GEOFFREY GATES Director SELL $20.77 50,000 $1,038,500 190,000 -20.8%
2021-10-28 03:23 2021-10-26 RICHMOND DONALD P. II Officer - VP of Engineering SELL $20.70 26,041 $538,994 92,116 -22.0%
2021-10-26 00:00 2021-10-21 SLAYEN HOWARD T Director SELL $21.50 10,000 $215,000 254,324 -3.8%
2021-10-19 00:07 2021-10-14 POSEDEL RHEA J Director SELL $21.03 25,000 $525,770 649,555 -3.7%
2021-10-16 00:00 2021-10-13 SCOTT GEOFFREY GATES Director SELL $21.11 50,000 $1,055,500 182,594 -21.5%
2021-10-16 00:00 2021-10-13 SLAYEN HOWARD T Director OPT+S $20.46 5,000 $102,288 262,309 0.0%
2021-10-14 00:00 2021-10-11 Brannan Michael A. Officer - V.P. of Operations OPT+S $18.80 17,000 $319,600 11,826 0.0%
2021-10-13 00:02 2021-10-08 POSEDEL RHEA J Director SELL $19.93 25,000 $498,220 674,555 -3.6%
2021-10-13 00:00 2021-10-08 RICHMOND DONALD P. II Officer - VP of Engineering SELL $18.87 13,915 $262,623 118,800 -10.5%
2021-10-09 03:51 2021-10-07 SCOTT GEOFFREY GATES Director SELL $15.70 110,000 $1,726,802 240,000 -31.4%
2021-10-09 03:42 2021-10-07 POSEDEL RHEA J Director SELL $15.00 20,000 $300,000 699,555 -2.8%
2021-10-09 00:02 2021-10-06 RICHMOND DONALD P. II Officer - VP of Engineering SELL $14.25 4,550 $64,843 132,715 -3.3%
2021-10-09 00:00 2021-10-06 SLAYEN HOWARD T Director SELL $14.59 15,481 $225,922 239,090 -6.1%
2021-10-01 04:09 2021-09-28 SPINK KENNETH B. Officer - VP of Finance and CFO OPT+S $14.13 133,914 $1,892,205 86,029 0.0%
2021-10-01 03:50 2021-09-28 ROSATI MARIO M Director OPT+S $14.09 3,800 $53,542 3,701 0.0%
2021-10-01 03:36 2021-09-28 ROGERS VERNON Officer - Exec. VP Sales and Marketing OPT+S $14.09 52,032 $733,131 47,018 0.0%
2021-09-30 23:01 2021-09-28 Brannan Michael A. Officer - V.P. of Operations SELL $14.24 9,073 $129,200 11,826 -43.4%
2021-09-30 23:01 2021-09-28 HENDRICKSON DAVID S Officer - CTO SELL $14.09 56,250 $792,563 44,726 -55.7%
2021-09-30 23:01 2021-09-28 Erickson Gayn Director, Officer - President and CEO SELL $14.19 206,567 $2,931,186 544,845 -27.5%
2021-09-30 23:01 2021-09-28 POSEDEL RHEA J Director SELL $14.08 150,000 $2,112,000 719,555 -17.3%
2021-08-19 03:29 2021-08-17 OLIPHANT LAURA Director OPT+S $5.30 25,000 $132,540 0 0.0%
2021-08-16 20:28 2021-08-12 Erickson Gayn Director, Officer - President and CEO OPT+S $5.78 17,000 $98,260 689,102 0.0%
2021-08-11 03:58 2021-08-09 SCOTT GEOFFREY GATES Director SELL $6.20 20,000 $124,000 332,594 -5.7%
2021-08-02 23:29 2021-07-30 Brannan Michael A. Officer - V.P. of Operations SELL $5.66 2,500 $14,150 20,899 -10.7%
2021-07-26 22:17 2021-07-22 SPINK KENNETH B. Officer - VP of Finance and CFO SELL $8.08 6,500 $52,508 114,054 -5.4%
2021-07-23 23:01 2021-07-21 OLIPHANT LAURA Director SELL $5.75 18,456 $106,122 30,376 -37.8%
2021-07-23 23:01 2021-07-21 POSEDEL RHEA J Director SELL $5.92 100,000 $592,460 847,055 -10.6%
2021-07-23 23:01 2021-07-21 SCOTT GEOFFREY GATES Director SELL $7.03 23,000 $161,591 250,000 -8.4%
2020-09-03 04:26 2020-09-02 FUCCI DAVID Other OPT+S $1.80 18,966 $34,228 1,488 0.0%
2020-08-20 02:52 2020-08-17 FUCCI DAVID Other OPT+S $2.10 200 $420 1,488 0.0%
2020-08-15 01:08 2020-08-12 Erickson Gayn Director, Officer - President and CEO SELL $2.08 59,900 $124,796 598,816 -9.1%
2020-05-15 01:25 2020-05-14 FUCCI DAVID Officer - VP of Operations SELL $1.52 547 $832 1,488 -26.9%
2020-04-01 20:11 2020-03-31 Erickson Gayn Director, Officer - President and CEO SELL $1.62 20,000 $32,400 474,015 -4.0%
2020-02-14 04:23 2020-02-12 POSEDEL RHEA J Director OPT+S $2.27 30,000 $68,100 48,794 0.0%
2020-02-14 01:27 2020-02-12 SANO KUNIO Officer - President of Aehr Test Japan OPT+S $2.27 1,000 $2,270 0 0.0%
2020-02-12 05:09 2020-02-10 SANO KUNIO Officer - President of Aehr Test Japan OPT+S $2.07 4,000 $8,260 0 0.0%
SHOW ENTRIES

How to Interpret $AEHR Trades

Not every insider transaction in Aehr Test Systems is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AEHR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for AEHR

Insider activity data for Aehr Test Systems is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AEHR, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.